These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24206782)

  • 1. Commentary to 'Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis'.
    Wu HY
    J Pediatr Urol; 2014 Apr; 10(2):323-4. PubMed ID: 24206782
    [No Abstract]   [Full Text] [Related]  

  • 2. Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.
    Guo F; Zhang LJ; Liu W; Wang G; Liu HY; Wang YL; Ma R; Wu RD
    J Pediatr Urol; 2014 Apr; 10(2):317-23. PubMed ID: 24119914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trial.
    Vokuhl C; Vogelgesang W; Leuschner I; Furtwängler R; Graf N; Gessler M; Dörner E; Pietsch T
    Genes Chromosomes Cancer; 2014 Nov; 53(11):960-2. PubMed ID: 25044466
    [No Abstract]   [Full Text] [Related]  

  • 4. Genotype-phenotype correlations: filling the void.
    Parsa A
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1542-3. PubMed ID: 20724521
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the letter to the editor: 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk satisfaction in the SIOP2009/Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) trial.
    Pritchard-Jones K; Williams R; Segers H; van den Heuvel-Eibrink M; Pieters R; van Tinteren H; Vujanic G; Bown N
    Genes Chromosomes Cancer; 2015 Jun; 54(6):397-9. PubMed ID: 25820248
    [No Abstract]   [Full Text] [Related]  

  • 6. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
    Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects of treatment for Wilms tumor.
    Green DM; Donckerwolcke R; Evans AE; D'Angio GJ
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1317-27. PubMed ID: 8591968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel case of Wilms' tumor followed by colon cancer, both showing microsatellite instability.
    Tsunematsu Y; Yoshizawa Y; Miyauchi J; Iijima T; Konishi M; Miyaki M
    Oncology; 2000 Feb; 58(2):159-60. PubMed ID: 10705243
    [No Abstract]   [Full Text] [Related]  

  • 11. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.
    Reid S; Renwick A; Seal S; Baskcomb L; Barfoot R; Jayatilake H; Pritchard-Jones K; Stratton MR; Ridolfi-Lüthy A; Rahman N; ;
    J Med Genet; 2005 Feb; 42(2):147-51. PubMed ID: 15689453
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephroblastic neoplasms.
    Khoury JD
    Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urogenital malformations associated with Wilms' tumor. Molecular genetic and clinical aspects].
    Zugor V; Schott GE
    Urologe A; 2007 Feb; 46(2):146, 148-9. PubMed ID: 17226050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms tumor: a success story in the developing world!
    Yadav SP; Manchanda H; Sachdeva A
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):632. PubMed ID: 23211687
    [No Abstract]   [Full Text] [Related]  

  • 15. The roles of microRNAs in Wilms' tumors.
    Yu X; Li Z; Chan MT; Wu WK
    Tumour Biol; 2016 Feb; 37(2):1445-50. PubMed ID: 26634744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital urogenital malformations associated with nephroblastomas. Long-term results of a study in Erlangen].
    Zugor V; Krot D; Schott GE
    Urologe A; 2007 Apr; 46(4):393-6. PubMed ID: 17285219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling Loss of Heterozygosity Patterns in a Cohort of Favorable Histology Nephroblastoma Egyptian Patients: What is Consistent With the Rest of the World.
    Fawzy M; Bahanassy A; Samir A; Hafez H
    Pediatr Hematol Oncol; 2015; 32(8):548-56. PubMed ID: 26390800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms tumors arising at young age: a genetic basis to distinguish subgroups for individualized therapy.
    Royer-Pokora B; Graf N
    J Clin Oncol; 2011 Jun; 29(16):e485-6; author reply e487-8. PubMed ID: 21519025
    [No Abstract]   [Full Text] [Related]  

  • 19. Heritable fraction of unilateral Wilms tumor.
    Li FP; Williams WR; Gimbrere K; Flamant F; Green DM; Meadows AT
    Pediatrics; 1988 Jan; 81(1):147-9. PubMed ID: 2827098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
    Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
    Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.